ASPI
$4.97
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes.
Recent News
ASP Isotopes (ASPI) Balances HALEU Ambitions With Securities Suit Progression – What Does It Signal?
In March 2026, Quantum Leap Energy LLC, a wholly owned ASP Isotopes subsidiary, signed a non-binding MOU with a major U.S. nuclear power operator to explore supporting new U.S.-based facilities for producing HALEU, LEU+ and providing uranium conversion and deconversion services, while securities fraud claims against ASP Isotopes were allowed to proceed in U.S. federal court. This combination of a potential role in strengthening America’s domestic nuclear fuel supply chain and ongoing...
A Look At ASP Isotopes (ASPI) Valuation After Nuclear Fuel MOU Sparks Fresh Interest
ASP Isotopes (ASPI) is back in focus after its subsidiary, Quantum Leap Energy, signed a non binding MOU with a large U.S. utility to explore support for U.S. based advanced nuclear fuel cycle facilities. See our latest analysis for ASP Isotopes. The MOU headlines come after a softer patch for the stock, with a 1 day share price return of 9.74% decline and a year to date share price return of 6.22% decline. However, the 1 year total shareholder return of 24.82% and very large 3 year total...
ASP Isotopes CEO Warns of New Helium Crunch, Details Renergen Ramp and Isotope Revenue Plans
ASP Isotopes (NASDAQ:ASPI) CEO Paul Mann said a renewed disruption in the global helium market is creating immediate supply pressure for industries ranging from semiconductors to medical imaging, while outlining how the company’s Renergen assets could add incremental supply later this decade. Mann m
Assessing ASP Isotopes (ASPI) Valuation After HALEU Deal And Expansion Plans
ASP Isotopes (ASPI) is back in focus after detailing expansion plans across nuclear medicine, semiconductors, and nuclear fuels, along with a planned spin off and new contracts tied to facility upgrades. See our latest analysis for ASP Isotopes. The recent expansion announcements and the HALEU collaboration with Necsa come after a period of mixed share price momentum. A 30 day share price return of 32.75% decline contrasts with a 12.18% 1 year total shareholder return and a very large 3 year...
What ASP Isotopes (ASPI)'s HALEU Venture and Nuclear Expansion Plans Mean For Shareholders
ASP Isotopes Inc. recently outlined its expansion plans across nuclear medicine, semiconductors, and nuclear fuels, while its Quantum Leap Energy subsidiary agreed with the South African Nuclear Energy Corporation to develop a High Assay Low Enriched Uranium enrichment facility at Necsa's Pelindaba site. This combination of a HALEU-focused collaboration and broader capacity upgrades positions ASP Isotopes more centrally within emerging advanced nuclear fuel supply chains. With these...